Yanez Michelle

Yanez Michelle is listed in filings as Chief Financial Officer at Telomir Pharmaceuticals, Inc. Common Stock. This profile follows SEC Form 4 activity through Dec 10, 2024, including 2 public disclosures. Recent filings connect the profile to Telomir Pharmaceuticals, Inc. Common Stock (TELO) and MIRA Pharmaceuticals, Inc. (MIRA). The current snapshot covers public activity from Sep 4, 2024 to Dec 10, 2024. Reported amounts are shown as $1.0M to $178.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.